Palamar, MelisAtes, HalilOztas, ZaferYusifov, Emil2019-10-272019-10-2720110021-5155https://doi.org/10.1007/s10384-011-0035-1https://hdl.handle.net/11454/46276To report the early results of suprachoroidal silicone implant surgery in intractable glaucoma. A modified silicone implant with no valve was implanted into the suprachoroidal space of 15 eyes with intractable glaucoma. The mean age of the patients was 53.0 +/- A 24.5 (range 7-85) years, the mean follow-up time was 17.1 +/- A 4.8 (range 10-28) months, and the mean preoperative intraocular pressure (IOP) of patients receiving two or more medications was 33.1 +/- A 9.8 mmHg. At the last follow-up visit, mean IOP was 16.5 +/- A 7.9 (range 10-35) mmHg (Wilcoxon signed rank test, p = 0.001). The functional success, i.e., IOP a parts per thousand currency sign21 mmHg both with and without antiglaucomatous drugs, was 93.3%. The total success rate, i.e., IOP a parts per thousand currency sign21 mmHg without medication, was 13.3%. The average number of antiglaucomatous drugs used was 3.8 (range 2-5) preoperatively, and 2.2 postoperatively (range 0-4) (Wilcoxon signed rank test, p = 0.011). There was a a parts per thousand yen30% decrease in the IOP of 66.6% of the eyes. Shallow choroidal detachment as proof of drainage was evident in all cases. Drainage of the aqueous humor from the anterior chamber to the suprachoroidal space via implantation of a modified silicone implant is effective in lowering the IOP in intractable glaucoma.en10.1007/s10384-011-0035-1info:eu-repo/semantics/closedAccessComplicationsGlaucomaGlaucoma drainage deviceIntraocular pressureSuprachoroidal implantArticle554351355WOS:00029347640000521617958Q1Q4